Dong Seok Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dong Seok Lee has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Yong Wook Jung
Department of Anatomy, Dongguk University School of Medicine, Gyeongju, Korea
4 shared publications- Kwan Lee
Department of Preventive Medicine, Dongguk University College of Medicine, Gyeongju, Korea
3 shared publications - Dilaram Acharya
Division of Nephrology, Department of Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada
2 shared publications - Seong-Su Moon
Department of Internal Medicine, Dongguk University College of Medicine, Gyeongju, Korea
2 shared publications - Seung Man Cho
Department of Pediatrics, Dongguk University School of Medicine, Gyeongju, Korea
2 shared publications Sung Min Choi
Department of Pediatrics, Dongguk University School of Medicine, Gyeongju, Korea
2 shared publications
Latest Publications
- Open Access
- 29 November 2020
- Published by MDPI AG in Healthcare
- Vol. 8 (4) , 518
Clinical Characteristics of the COVID-19 Patients with Pneumonia Detected by Computerized Tomography but Negative for Infiltration by X-ray
Coronavirus Disease 2019 (COVID-19) has rapidly spread to all corners of the globe. Different diagnostic tools, such as Chest X-ray (CXR), lung ultrasound (LUS), and computerized tomography (CT), have been used to detect active pneumonic lesions associated with COVID-19 with their varying degrees of sensitivity and specificity. This study was undertaken to investigate the clinical characteristics of COVID-19 patients with a pneumonic lung lesion detected by CT that is not detected by CXR. A total of 156 COVID-19 patients hospitalized at three nationally designated South Korean hospitals with no active lesion detected by CXR but on clinical suspicion of pneumonia underwent the CT examination and were enrolled. Medical records, which included demographic and clinical features, including comorbidity, symptoms, radiological, and laboratory findings on admission, were reviewed and analyzed. The risk factors of pneumonia detected by CT for patients without an active lesion detected by CXR were investigated. Of the 156 patients without an active lesion detected by CXR, 35 (22.44%) patients were found to have pneumonia by CT. The patients with pneumonia defined by CT were older than those without (64.1 years vs. 41.2 years). Comorbidities such as hypertension, diabetes, cardiovascular disease, preexisting stroke, and dementia were more common among patients with pneumonia defined by CT than those without. Serum albumin level, C-reactive protein (CRP), stroke, and age ≥ 70 years were significantly associated with pneumonia defined by CT after adjustment for age. In multivariable regression analysis, serum albumin level (adjusted odds ratio (AOR) = 0.123, 95% CI = (0.035–0.429)) and preexisting stroke (AOR = 11.447, 95% CI = (1.168–112.220)) significantly and independently predicted pneumonia detection by CT. Our results suggest that CT scans should be performed on COVID-19 patients negative for a pneumonic lung lesion by CXR who are suspected to be pneumonic on clinical grounds. In addition, older patients with a lower albumin level and a preexisting stroke should be checked for the presence of pneumonia despite a negative CXR finding for an active lesion.
- 29 November 2020
- Published by MDPI AG in Healthcare
- Vol. 8 (4) , 518
Open AccessClinical Characteristics of the COVID-19 Patients with Pneumonia Detected by Computerized Tomography but Negative for Infiltration by X-ray
Coronavirus Disease 2019 (COVID-19) has rapidly spread to all corners of the globe. Different diagnostic tools, such as Chest X-ray (CXR), lung ultrasound (LUS), and computerized tomography (CT), have been used to detect active pneumonic lesions associated with COVID-19 with their varying degrees of sensitivity and specificity. This study was undertaken to investigate the clinical characteristics of COVID-19 patients with a pneumonic lung lesion detected by CT that is not detected by CXR. A total of 156 COVID-19 patients hospitalized at three nationally designated South Korean hospitals with no active lesion detected by CXR but on clinical suspicion of pneumonia underwent the CT examination and were enrolled. Medical records, which included demographic and clinical features, including comorbidity, symptoms, radiological, and laboratory findings on admission, were reviewed and analyzed. The risk factors of pneumonia detected by CT for patients without an active lesion detected by CXR were investigated. Of the 156 patients without an active lesion detected by CXR, 35 (22.44%) patients were found to have pneumonia by CT. The patients with pneumonia defined by CT were older than those without (64.1 years vs. 41.2 years). Comorbidities such as hypertension, diabetes, cardiovascular disease, preexisting stroke, and dementia were more common among patients with pneumonia defined by CT than those without. Serum albumin level, C-reactive protein (CRP), stroke, and age ≥ 70 years were significantly associated with pneumonia defined by CT after adjustment for age. In multivariable regression analysis, serum albumin level (adjusted odds ratio (AOR) = 0.123, 95% CI = (0.035–0.429)) and preexisting stroke (AOR = 11.447, 95% CI = (1.168–112.220)) significantly and independently predicted pneumonia detection by CT. Our results suggest that CT scans should be performed on COVID-19 patients negative for a pneumonic lung lesion by CXR who are suspected to be pneumonic on clinical grounds. In addition, older patients with a lower albumin level and a preexisting stroke should be checked for the presence of pneumonia despite a negative CXR finding for an active lesion.
- Open Access
- 13 September 2020
- Published by MDPI AG in Healthcare
- Vol. 8 (3) , 338
Mortality Rate and Predictors of Mortality in Hospitalized COVID-19 Patients with Diabetes
Studies have confirmed COVID-19 patients with diabetes are at higher risk of mortality than their non-diabetic counterparts. However, data-driven evidence of factors associated with increased mortality risk among hospitalized COVID-19 patients with diabetes is scarce in South Korea. This study was conducted to determine the mortality rate and identify risk factors of mortality among hospitalized COVID-19 patients with type 2 diabetes in Gyeongsangbuk-do province, South Korea. In this hospital-based, cross-sectional study, we enrolled a total of 324 patients with confirmed COVID-19, hospitalized at two of the tertiary level healthcare facilitates of Gyeongsangbuk-do, South Korea from 18 February to 30 June 2020. Demographic and clinical data and laboratory profiles were analyzed and multivariate logistic regression analysis was used to identify risk factors of mortality among diabetic patients with COVID-19. Of the 324 patients, 55 (16.97%) had diabetes mellitus. The mean age of all study subjects was 55 years, and the mean age of those with diabetes was greater than that of those without (69.8 years vs. 51.9 years). Remarkably, the mortality rate was much higher among those with diabetes (20.0% vs. 4.8%). Multivariate logistic regression analysis revealed that an older age (≥70 years) and a high serum lactate dehydrogenase (LDH) levels significantly predicted mortality among hospitalized COVID-19 patients with diabetes. Our study cautions more attention to be paid to patients with diabetes mellitus hospitalized for COVID-19, especially those aged ≥ 70 years and those with a high serum LDH level, to reduce the risk of mortality.
- 13 September 2020
- Published by MDPI AG in Healthcare
- Vol. 8 (3) , 338
Open AccessMortality Rate and Predictors of Mortality in Hospitalized COVID-19 Patients with Diabetes
Studies have confirmed COVID-19 patients with diabetes are at higher risk of mortality than their non-diabetic counterparts. However, data-driven evidence of factors associated with increased mortality risk among hospitalized COVID-19 patients with diabetes is scarce in South Korea. This study was conducted to determine the mortality rate and identify risk factors of mortality among hospitalized COVID-19 patients with type 2 diabetes in Gyeongsangbuk-do province, South Korea. In this hospital-based, cross-sectional study, we enrolled a total of 324 patients with confirmed COVID-19, hospitalized at two of the tertiary level healthcare facilitates of Gyeongsangbuk-do, South Korea from 18 February to 30 June 2020. Demographic and clinical data and laboratory profiles were analyzed and multivariate logistic regression analysis was used to identify risk factors of mortality among diabetic patients with COVID-19. Of the 324 patients, 55 (16.97%) had diabetes mellitus. The mean age of all study subjects was 55 years, and the mean age of those with diabetes was greater than that of those without (69.8 years vs. 51.9 years). Remarkably, the mortality rate was much higher among those with diabetes (20.0% vs. 4.8%). Multivariate logistic regression analysis revealed that an older age (≥70 years) and a high serum lactate dehydrogenase (LDH) levels significantly predicted mortality among hospitalized COVID-19 patients with diabetes. Our study cautions more attention to be paid to patients with diabetes mellitus hospitalized for COVID-19, especially those aged ≥ 70 years and those with a high serum LDH level, to reduce the risk of mortality.
- Open Access
- 1 January 2020
- Published by XMLink in Journal of Korean Medical Science
- Vol. 35 (36)
Clinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals
Moon SS, et al. J Korean Med Sci. 2020 Aug;35(36):e328. https://doi.org/10.3346/jkms.2020.35.e328
- 1 January 2020
- Published by XMLink in Journal of Korean Medical Science
- Vol. 35 (36)
Open AccessClinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals
Moon SS, et al. J Korean Med Sci. 2020 Aug;35(36):e328. https://doi.org/10.3346/jkms.2020.35.e328
- Open Access
- 15 June 2019
- Published by Korean Pediatric Society in Korean Journal of Pediatrics
- Vol. 62 (6) , 213-214
Does any specific infection cause Kawasaki disease?
- 15 June 2019
- Published by Korean Pediatric Society in Korean Journal of Pediatrics
- Vol. 62 (6) , 213-214
Open AccessDoes any specific infection cause Kawasaki disease?
- Open Access
- 1 January 2015
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 45 (6) , 510-515
Early Detection of Kawasaki Disease in Infants
Kang JH, et al. Korean Circ J. 2015 Nov;45(6):510-515. http://dx.doi.org/10.4070/kcj.2015.45.6.510
- 1 January 2015
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 45 (6) , 510-515
Open AccessEarly Detection of Kawasaki Disease in Infants
Kang JH, et al. Korean Circ J. 2015 Nov;45(6):510-515. http://dx.doi.org/10.4070/kcj.2015.45.6.510
- Open Access
- 1 January 2010
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 40 (12) , 659-664
Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a life threatening disease characterized by progressive pulmonary arterial occlusion which may ultimately result in death. Currently, the available treatments are diverse, but no therapy alone can reverse the disease process although they may have some clinical benefits. This study was designed to investigate single and combination therapy of simvastatin and sildenafil, which have different mechanisms of action, in monocrotaline (MCT)-induced PAH. Rats were randomized to receive saline (control, n=8) or MCT treatment (n=32). MCT treated rats were randomized to vehicle, simvastatin (2 mg/kg/day), sildenafil (25 mg/kg/day) and a combination simvastatin and sildenafil (n=8, respectively). Three weeks later, hemodynamic study and histologic changes of pulmonary arterioles were measured. Proliferating cell nuclear antigen (PCNA) as well as Western blot for endothelial nitric oxide synthase (eNOS) were performed. Systolic right ventricular pressure was significantly decreased in monotherapy groups (simvastatin and sildenafil) and the combination group compared to MCT group (p<0.05). Right ventricular hypertrophy and medial wall thickness of pulmonary arterioles were significantly attenuated with sole and combination therapy (p<0.05). However, combination therapy did not confer additive benefits over monotherapy. Altered PCNA or eNOS in lung tissue was normalized by either monotherapy or combination therapy. The results suggest that either simvastatin or sildenafil has the therapeutic potential in MCT-induced PAH, although combination therapy of these two drugs has failed to show greater benefits in the study.
- 1 January 2010
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 40 (12) , 659-664
Open AccessSimvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a life threatening disease characterized by progressive pulmonary arterial occlusion which may ultimately result in death. Currently, the available treatments are diverse, but no therapy alone can reverse the disease process although they may have some clinical benefits. This study was designed to investigate single and combination therapy of simvastatin and sildenafil, which have different mechanisms of action, in monocrotaline (MCT)-induced PAH. Rats were randomized to receive saline (control, n=8) or MCT treatment (n=32). MCT treated rats were randomized to vehicle, simvastatin (2 mg/kg/day), sildenafil (25 mg/kg/day) and a combination simvastatin and sildenafil (n=8, respectively). Three weeks later, hemodynamic study and histologic changes of pulmonary arterioles were measured. Proliferating cell nuclear antigen (PCNA) as well as Western blot for endothelial nitric oxide synthase (eNOS) were performed. Systolic right ventricular pressure was significantly decreased in monotherapy groups (simvastatin and sildenafil) and the combination group compared to MCT group (p<0.05). Right ventricular hypertrophy and medial wall thickness of pulmonary arterioles were significantly attenuated with sole and combination therapy (p<0.05). However, combination therapy did not confer additive benefits over monotherapy. Altered PCNA or eNOS in lung tissue was normalized by either monotherapy or combination therapy. The results suggest that either simvastatin or sildenafil has the therapeutic potential in MCT-induced PAH, although combination therapy of these two drugs has failed to show greater benefits in the study.
- Open Access
- 1 January 2008
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 38 (6) , 313-319
The Protective Effect of Simvastatin on Monocrotaline-Induced Pulmonary Hypertension in Rats
Kim MY, et al. Korean Circ J. 2008 Jun;38(6):313-319. https://doi.org/10.4070/kcj.2008.38.6.313
- 1 January 2008
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 38 (6) , 313-319
Open AccessThe Protective Effect of Simvastatin on Monocrotaline-Induced Pulmonary Hypertension in Rats
Kim MY, et al. Korean Circ J. 2008 Jun;38(6):313-319. https://doi.org/10.4070/kcj.2008.38.6.313
- Open Access
- 1 January 2006
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 36 (10) , 683-687
Resveratrol Attenuates Monocrotaline-Induced Pulmonary Hypertension in Rats
Lee DS, et al. Korean Circ J. 2006 Oct;36(10):683-687. http://dx.doi.org/10.4070/kcj.2006.36.10.683
- 1 January 2006
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 36 (10) , 683-687
Open AccessResveratrol Attenuates Monocrotaline-Induced Pulmonary Hypertension in Rats
Lee DS, et al. Korean Circ J. 2006 Oct;36(10):683-687. http://dx.doi.org/10.4070/kcj.2006.36.10.683
- Open Access
- 1 January 2005
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 35 (9) , 665-671
Bosentan Attenuates Compensatory Left Ventricular Hypertrophy Induced by Aortocaval Fistula in Rats
Lee DS, et al. Korean Circ J. 2005 Sep;35(9):665-671. http://dx.doi.org/10.4070/kcj.2005.35.9.665
- 1 January 2005
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 35 (9) , 665-671
Open AccessBosentan Attenuates Compensatory Left Ventricular Hypertrophy Induced by Aortocaval Fistula in Rats
Lee DS, et al. Korean Circ J. 2005 Sep;35(9):665-671. http://dx.doi.org/10.4070/kcj.2005.35.9.665